Allergic rhinitis is a type of allergy that affects most number of people. 10 to 30 % of population in western countries are infected with allergic rhinitis in a year.
Allergic rhinitis is allergy caused by pollen or dust in which mucous membranes of the nose and eyes are inflamed that causes running nose and watery eyes.
Allergy Therapeutics (LON:AGY)is an international commercial biotechnology company focused on the treatment and diagnosis of allergic disorders, including immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third party products from its subsidiaries in nine major European countries and via distribution agreements in an additional fourteen countries. Its broad pipeline of products in clinical development include vaccines for grass, tree and house dust mite, and peanut allergy vaccine in pre-clinical development. Adjuvant systems to boost performance of vaccines outside allergy are also in development.